Fluorotechnics Expands Global Capability via Acquisition of ETC Elektrophorese-Technik
News Nov 14, 2007
Fluorotechnics has announced the acquisition of ETC Elektrophorese-Technik. Under the terms of the acquisition, Fluorotechnics will acquire all issued shares in ETC Elektrophorese-Technik in exchange for Fluorotechnics shares.
ETC Elektrophorese-Technik develops and manufactures high-end electrophoresis consumables and equipment used for diagnostics, quality control and species identification. Fluorotechnics is a developer and manufacturer of fluorescent research tools that are used in proteomics, cell biology and biochemistry.
Fluorotechnics CEO, Duncan Veal, states,” We are very excited by the synergies that the combination of the two companies will bring. This acquisition will allow us to cross-sell products to existing customers and to address new markets utilizing our joint expertise. Our ever-expanding sales and marketing team and enormous potential for our product offering means that we are well positioned for strong growth.”
Hanspeter Schickle, CEO of ETC, said,” We know that our customers will welcome the extended offering and complete solution that the range of Fluorotechnics and ETC products will now provide. The merged group possesses exceptional expertise, has a dynamic product pipeline and is set to become a leading supplier to life-scientists, globally.”
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.